These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 10623688)

  • 1. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
    Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
    J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
    Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
    Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
    Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
    Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
    Antoneli CB; Ribeiro KC; Steinhorst F; Novaes PE; Chojniak MM; Malogolowkin M
    J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.
    Friedman DL; Krailo M; Villaluna D; Gombos D; Langholz B; Jubran R; Shields C; Murphree L; O'Brien J; Kessel S; Rodriguez-Galindo C; Chintagumpala M; Meadows AT
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28019092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
    Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
    Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
    Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy.
    Lumbroso-Le Rouic L; Aerts I; Hajage D; Lévy-Gabriel C; Savignoni A; Algret N; Cassoux N; Bertozzi AI; Esteve M; Doz F; Desjardins L
    Eye (Lond); 2016 Jan; 30(1):46-52. PubMed ID: 26427984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
    Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
    Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.